EnsoData provides a Software-as-a-Service platform that uses AI to analyze sleep-wake waveform data for medical diagnostics. Its flagship EnsoSleep automates sleep-study scoring by processing signals such as EEG and ECG to detect disorders and measure total sleep time, with in-lab and home-study support plus a viewing/editing platform and ongoing FDA-cleared enhancements like EnsoSleep PPG using pulse oximeter data. The solution is designed to integrate with existing sleep-lab software and electronic health records to fit into clinicians’ workflows. The company's goals are to improve diagnostic efficiency and accuracy in sleep medicine, expand into related areas like cardiology and neurology, and grow its commercial footprint by providing scalable AI-powered clinical decision support to sleep clinics, hospitals, and care providers.
Company Size
51-200
Company Stage
Series B
Total Funding
$51.1M
Headquarters
Madison, Wisconsin
Founded
2015
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?